Delivery Order SPE2DR25D2101-SPE2DR26F46UB
- Not listed
- The Defense Logistics Agency awarded a $12,467.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 mL on-body injection units on December 8, 2025. The delivery order, which represents a child contract under AmerisourceBergen's larger DLA relationship, requires completion by December 30, 2025, and will be performed at the company's headquarters in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation....
- The Defense Logistics Agency awarded a delivery order valued at $18,646.03 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL, a pharmaceutical product, on December 9, 2025. This firm fixed price, non-set-aside delivery order is due for completion by December 10, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $17,574.35 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen vials under a firm fixed price contract type. This competitive award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery location is specified as Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a $12,467 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body injectable units. The contract was awarded on December 22, 2025, with an ultimate completion date of January 14, 2026, and involves performance at the contractor's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,898.42 for SKYRIZI 600 mg/10 mL vials on December 11, 2025, with an ultimate completion date of January 5, 2026. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $12,467.00 to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of SKYRIZI 360 MG/2.4 ML on-body injectable medication. This firm fixed-price delivery order, with an ultimate completion date of December 16, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $25,899.93 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors, with an ultimate completion date of July 14, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $35,434.03 to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of SKYRIZI 150 mg/mL pen injections. This firm fixed price delivery order, which is not set-aside designated, represents a competitive award under the federal medical procurement process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 21, 2025. This...
- The Defense Logistics Agency awarded a $41,824.89 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen medication on September 2, 2025, with completion expected by September 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under a larger procurement vehicle. This delivery order...
- The Defense Logistics Agency awarded a $12,467.00 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body 2.4ML injectable medication, with an ultimate completion date of December 18, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The place of performance is...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46UBDelivery Order
The Defense Logistics Agency awarded a $24,438.64 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL injectable pharmaceutical product on December 22, 2025, with completion scheduled for December 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The pharmaceutical will be delivered to the Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and distribution center. This delivery order falls under AmerisourceBergen Drug Corp's substantial $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, and medical supplies to support military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. SKYRIZI, a specialty biologic medication, exemplifies the range of brand-name pharmaceuticals that AmerisourceBergen delivers through this critical procurement vehicle supporting federal medical supply needs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 12/21/25 |